Copy number variation in human health, disease, and evolution

Area of Science:

• Genetics
• Genomics
• Molecular Biology

Background:

• Copy number variation (CNV) represents a significant source of genetic diversity in the human population.
• CNVs are increasingly identified using advanced genomic analysis platforms such as next-generation sequencing and SNP genotyping.
• Both recombination-based and replication-based mechanisms contribute to CNV formation, with higher de novo mutation rates compared to single nucleotide polymorphisms (SNPs).

Purpose of the Study:

• To explore the mechanisms of copy number variation formation and its impact on human genetic diversity.
• To discuss the role of CNVs in causing Mendelian and complex diseases, as well as their potential as benign variants.
• To highlight the significance of CNVs in driving gene and genome evolution.

Main Methods:

• Genome analysis platforms including array comparative genomic hybridization (aCGH), SNP genotyping, and next-generation sequencing are utilized for CNV identification.
• Molecular mechanisms underlying CNV formation, such as recombination and replication errors, are investigated.
• Analysis of CNV impact on gene dosage, disruption, fusion, and positional effects is performed.

Main Results:

• CNVs are identified through multiple high-throughput genomic technologies.
• CNV formation involves diverse molecular mechanisms and exhibits higher de novo mutation rates than SNPs.
• CNVs can lead to various traits and diseases through mechanisms like gene dosage alteration and disruption, but can also be benign polymorphisms.

Conclusions:

• Copy number variations are a major driver of genetic diversity and evolution.
• CNVs play a dual role in human health, contributing to disease while also representing normal polymorphic variation.
• Advanced genomic tools facilitate the comprehensive study of CNVs and their multifaceted biological roles.